9th ESNI Course 2009

2009 – 9th ESNI COURSE | Istanbul (Turkey) | 1-4 September

I Day

Neuroscience and neurobiology: basic aspects

  • The host defense of Drosophila melanogaster (Dominique Ferrandon)
  • Immune response in plants (Saskia van Wees)
  • The inflammasome: a new entry (Stefan Drexler)
  • Autophagy in autoimmunity (Francesco Cecconi)
  • The immunomodulatory role of neural stem cells (Stefano Pluchino)
  • Astrocytes, inflammation and neurodegeneration (Trevor Owens)
  • From Th1 to Th17: relevance for CNS autoimmunity (Burkhard Becher)
  • The role of infection in CNS autoimmunity (Matthias Von Herrath)

II Day

Basic and clinical aspects of neuroinflammation

  • Genetics of animal models of CNS inflammation (Maja Jagodic)
  • Innate immunity in the progression of inflammatory neurodegen (Christine Dijkstra)
  • T cells in CNS tissue damage (Roland Liblau)
  • Neuronal control of brain inflammation (Lesley Probert)
  • Evolving neuropathological characterization of multiple sclero (Hans Lassmann)
  • Ion channels as therapeutic targets of neurodegeneration n (Ken Smith)
  • Dendritic cells and antigen presentation in the CNS during autoimmune disease. (Adi Vaknin-Dembinsky)
  • B cells in multiple sclerosis pathogenesis (Francesca Aloisi)


Basic and clinical aspects of immune-mediated neuromuscular disorders

  • Mouse models of human neuromuscular disorders in vivo and ex vivo: a behavioural and physiological perspective (Jaap Plomp)
  • How to study the node of Ranvier: a cell biologist’s perspective (Elior Peles)
  • Acquired peripheral neuropathies; from inflammation to demyelination (Angelo Quattrini )
  • Inflammatory components to genetic neuropathies: seeing is believing. (Rudolf Martini)
  • What’s new and clinically useful in the anti-nerve antibody field? (Bart Jacobs )
  • Establishing novel diagnostic assays in a clinical neuroimmunology laboratory setting (Angela Vincent)
  • Clinical research in motor nerve terminal and neuromuscular junction disorders (Jan Verschuuren)
  • Developments in the scientific and clinical understanding of inflammatory myopathies (Ingrid Lundberg)

IV Day

Pathogenesis and therapy of multiple sclerosis

  • Understanding multiple sclerosis pathogenesis: what animal models have taught us? (Chris Linington)
  • Myelin repair in CNS: Role for guidance molecules (Catherine Lubetzki)
  • B cell immunology and multiple sclerosis: implications for treatment and data from clinical trials (Amit Bar-Or)
  • What can we learn from treating multiple sclerosis? (Orhan Aktas)
  • Scientific thinking; science education and ethics(Emin Kansu)
  • Potential new players on multiple sclerosis therapy: an introductory overview (Rana Karabudak)
  • Lysophospholipids as mediators of immunity (Orhan Aktas)
  • Oral fingolimod and teriflunomide: mechanism of action, pre-clinical and clinical data in multiple sclerosis (Gulsen Akman-Demir)
  • Rescue treatments: urgent treatments need for transitional stage multiple sclerosis (Orhun Kantarci)

Final Program